Vincent DiPippo

Title: Vincent DiPippo: Innovator in Nucleic Acids and Toxicology

Introduction

Vincent DiPippo is a notable inventor based in East Haven, CT (US). He has made significant contributions to the fields of molecular biology and toxicology, holding 2 patents that showcase his innovative work.

Latest Patents

DiPippo's latest patents include groundbreaking inventions in the realm of proteins and nucleic acids. One of his patents, titled "Proteins and nucleic acids encoding same," discloses nucleic acid sequences that encode novel polypeptides. This invention also details the polypeptides encoded by these sequences, along with antibodies that specifically bind to the polypeptide. Furthermore, it outlines therapeutic, diagnostic, and research methods for diagnosing, treating, and preventing disorders associated with these novel human nucleic acids and proteins. Another significant patent is "Method of identifying toxic agents using NSAID-induced differential gene expression in liver." This invention provides methods for identifying toxic agents, particularly hepatotoxic agents, through differential gene expression. It also includes methods for predicting the risk level and injury type of NSAIDs, along with novel nucleic acid sequences whose expression is differentially regulated by NSAIDs.

Career Highlights

Throughout his career, DiPippo has worked with various organizations, including Curagen Corporation. His work has significantly impacted the understanding of molecular mechanisms in health and disease.

Collaborations

DiPippo has collaborated with notable individuals in his field, including Peter S Mezes and Luca Rastelli. These collaborations have further enriched his research and contributions to science.

Conclusion

Vincent DiPippo's innovative work in nucleic acids and toxicology has led to valuable patents that advance our understanding of molecular biology. His contributions continue to influence research and therapeutic approaches in these critical areas.